BLISSGVS quarterly results and annual financials: sales, operating profit, OPM, net profit, EPS, balance sheet, cash flow and ratios like ROCE, with YoY and QoQ growth.
Bliss GVS Pharma Ltd reported sales of ₹313 Cr, operating profit of ₹81 Cr (OPM 26%) and net profit of ₹53 Cr for the quarter ended Sep 2026. Figures in ₹ crore, consolidated where available.
BLISSGVS quarterly results (₹ Cr)
Metric
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Sep 2026
Sales
210
198
207
244
218
257
286
313
Expenses
181
177
166
201
183
213
209
233
Operating Profit
30
21
41
43
35
44
76
81
OPM
14%
11%
20%
18%
16%
17%
27%
26%
Other Income
15
12
35
8
16
11
10
8
Interest
1
2
5
3
1
2
1
3
Depreciation
8
8
8
8
8
9
10
10
Profit before tax
36
23
63
41
41
45
75
75
Tax
29%
29%
30%
30%
39%
18%
32%
29%
Net Profit
26
17
44
29
25
37
51
53
EPS in Rs
2.26
1.47
4.08
2.58
2.2
3.36
4.72
4.91
BLISSGVS profit & loss, annual (₹ Cr)
Metric
Mar 2022
Mar 2023
Mar 2024
Mar 2025
Mar 2026
TTM
Sales
747
752
770
810
927
1,074
Expenses
629
634
620
683
760
838
Operating Profit
118
117
151
127
168
236
OPM
16%
16%
20%
16%
18%
22%
Other Income
-42
18
0
36
67
45
Interest
5
10
7
8
12
7
Depreciation
17
19
26
29
33
37
Profit before tax
54
106
117
126
190
236
Tax
57%
28%
30%
28%
29%
-
Net Profit
23
77
82
90
135
166
EPS in Rs
1.45
6.8
7.21
8
12.21
15.19
Dividend Payout
34%
7%
7%
6%
4%
-
BLISSGVS balance sheet (₹ Cr)
Metric
Mar 2024
Mar 2025
Sep 2025
Mar 2026
Sep 2026
Equity Capital
10
11
11
11
11
Reserves
957
1,040
1,122
1,182
1,280
Borrowings
100
88
52
22
23
Other Liabilities
145
163
215
278
269
Total Liabilities
1,212
1,301
1,400
1,492
1,582
Fixed Assets
370
406
392
459
471
CWIP
8
21
39
6
8
Investments
4
4
10
5
4
Other Assets
830
871
959
1,022
1,100
Total Assets
1,212
1,301
1,400
1,492
1,582
BLISSGVS cash flows (₹ Cr)
Metric
Mar 2022
Mar 2023
Mar 2024
Mar 2025
Mar 2026
Cash from Operating Activity
135
34
103
106
139
Cash from Investing Activity
-103
-6
-83
-75
-38
Cash from Financing Activity
-24
-25
-21
-30
-89
Net Cash Flow
9
3
-1
0
11
Free Cash Flow
63
-59
75
33
84
CFO/OP
143%
67%
91%
112%
108%
CFO/EBITDAShare of operating profit converting into cash: CFO (before tax) / Operating Profit